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从 14种海藻样品中共分离得到 81株海藻真菌。采用 PD和 GPY 2
种液体培养基进行发酵，分别以 MTT 法和纸片法对这些菌株发酵液
乙酸乙酯抽提物的抗肿瘤活性及抗菌活性进行测定。结果表明，有
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有 47株对至少一株指示菌有显著抑制作用，占供测菌株的 58%。采





和重结晶等分离纯化方法从 LC13 菌株中分离到了 7 个单体化合物
（Z1、Z3-Z6、Z8和 Z9）。Z3、Z8的结构分别鉴定为 5,8-表二氧麦角
甾 - 6 , 9 ( 1 1 ) , 2 2 -三烯 - 3β -醇和谷甾醇。Z 6 的结构鉴定为 
5,11-Dimethyl-1,2,7,8-tetrahydro-3,9-dioxa-6b,12b-diaza-perylene， 





定了 Z10 和 Z15 两个化合物。Z10 为麦角甾醇；Z15 初步确定为 1
氢,1′氢-[2,2′]二嘧啶-4,4′-二酮，是新化合物。 
对以上化合物进行抗肿瘤、抗菌和抗乙酰胆碱酯酶的活性分析。
经检测，Z3、Z8 和 Z9 对 Raji 肿瘤细胞株有微弱的抑制作用，IC50
分别为 150、122.1和 100µg/mL。新化合物 Z15对MG-63肿瘤细胞
株的 IC50为 151.2µg/mL，对交链孢霉的MIC为 50µg/mL。组分 Z14
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    本文的工作表明，海藻真菌中蕴藏着丰富的抗菌、抗肿瘤和抗
乙酰胆碱酯酶活性物质，是开发新药的潜在资源。 
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Abstract 
Marine microorganisms have become an important source of phar- 
macologically active metabolites.  More specically,  fungi from  the 
marine environment have shown great potential. There are innumerable 
kinds of marine fungi, which distribute widely in all kinds of environ- 
ment, such as sponge, alga, coral,mangrove and so on. 
Today there are about three hundreds new compounds derived for 
marine fungi. Marine fungi obtained from either sponges, algae, or wood 
substrates account for the majority of new compounds  reported from 
marine fungi. Interestingly, sponge-derived fungi account for the largest 
number (33%) of total compounds and have the overall highest number 
of novel metabolites. Algicolous fungi are second accounting for 24% of 
the total number of compounds, but represent a slightly higher percenta- 
ge (27%) of new metabolites. Additionally, the ratio of new metabolites 
to known metabolites is much higher for algicolous fungi  as compared 
to sponge-derived fungi. Alough algicolous fungi is such a promising 
resource, it’s relatively little investigated.  
Fourteen marine algae samples investigated in this study  originated 
from different intertidal zones of Fujian Province,  China.  From those 
algae,  eighty one strains of algicolous fungi  were isolated by  using 
selective media. Those fungi were cultured on  PD medium  and GPY 
medium. Organic extracts were screened by the way of MTT  and Disk 
diffusion susceptibility. The results showed that 49 strains  (60% of the 
total isolates) could inhibit the growth of Raji and/or KB tumor cell lines, 
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activities against one or more sensitive microbes  ( Bacillus  subtilis, 
Escherichia coli, Staphlococcus aureus, Candida albicans, Aspergillus 
niger). At the same time,  65 strains of the all strains were screened for 
acetylcholinesterase inhibitors.  As a result,  10 strains could  inhibit 
acetylcholinesterase.   
Two algicolous fungi LC13（Nigrospora  sp.）and PT2（Trichoderma 
sp.）were selected to study their secondary metabolites. Employing VLC
（Vacuum Liquid Chromatography）,Silica Column Chromatography, 
Dextran gel Column Chromatography,HPLC and re-crystal, we isolated 
seven compounds（Z1,Z3-Z6,Z8 and Z9）from LC13. The structures of 
Z3 and Z8 were identified as5,8-epidioxy-5a,8a-stigmasta-6,9(11),22- 
trien-3β-ol and β-sitosterol individually. The new compound,Z6, was 
identified as 11-Dimethyl-1,2,7,8-tetrahydro-3,9-dioxa-6b,12b-diaza- 
perylene. The structure elucidating of other compouds was undergoing. 
From another algicolous fungi PT2（Trichoderma sp.）, a mixture(Z14) of 
two cyclopeptides was gained. The amino acid composition in Z14 had 
been measured. With the aid of MS and NMR, the structure elucidating 
of Z14 was undergoing. 
We also studied the metabolites from a lignicolous fungi 
HLY2(Diaporthe phaseolorum) .As a result, we got and elucidated two 
compounds(Z10 and Z15),their structure were identified as ergosterol 
and 1H,1′H-[2,2′]Bipyrimidinyl-4,4′-dione respectively. Between 
then,Z15 is a new compound. 
In the later investigation of antitumor, antimicrobial and 
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inhibit the growth of Raji cell line, the value of their IC50 was 150，122.1 
and 100µg/mL respectively. The new compound ,Z15, showed antitumor 
activity against MG-63 cell line with IC50 151.2µg/mL. Also it showed 
antimicrobial activity against Alternaria sp.with MIC 50µg/mL. 
Z14 demonstrated significantly bioactivity against four human 
tumor cell lines(KB，Raji，Hela and MG-63), their IC50 were 0.9，6.4，
25 and 10.5µg/mL individually. Its MIC against Bacillus subtilis is 
100µg/mL.  
    Our study indicated that algicolous fungi was reliable resource for 
metabolites with antitumor, antimicrobial and acetycholinesterase 
inhibitory activities. 







































































Tab.1 New Chemical Entities and Medical Indications by Source of 
Compound, 1981-2002 
 

























































Fig.2 Novel organic molecules reported from marine prokaryotes, 





Fig.3 Novel organic molecules reported from marine fungi, cited in 


















究进展较缓慢，据报道从 1970 年至 1993 年从海洋真菌中发现的新
化合物不到 35 个，直到 1994 年开始，发现新化合物的速率才有所
增加，进入较快速的发展阶段（图 4）[28]。 
 
图 4 每年报道的海洋真菌新化合物数量 

































图 5 已报道的所有海洋真菌次级代谢产物的分布 
Fig.5 The distribution of all compounds reported from marine 
derived fungi is shown as a function of the fungal source. 
 
 
图 6 已报道的来源于海洋真菌的新化合物的分布 
Fig.6 The distribution of all new compounds reported from marine 
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